We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+13.94%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
10 Year Est. Return
AUM
$518M
AUM Growth
+$159M
Cap. Flow
+$131M
Cap. Flow %
25.19%
Top 10 Hldgs %
65.06%
Holding
140
New
98
Increased
11
Reduced
9
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 53.22%
2 Financials 20.04%
3 Technology 17.47%
4 Consumer Discretionary 1.45%
5 Industrials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDAQW
76
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$15.9K ﹤0.01%
+265,481
New +$17.8K
UWMC.WS
77
DELISTED
UWM Holdings Warrants
UWMC.WS
$15K ﹤0.01%
+25,000
New +$13.5K
XFINW
78
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$15K ﹤0.01%
+100,000
New +$4.89K
EVE.WS
79
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$13.8K ﹤0.01%
+274,999
New +$18.6K
SDSTW
80
Stardust Power Inc Warrant
SDSTW
$13K ﹤0.01%
+31,666
New +$14.5K
ZEOWW
81
Zeo Energy Corp Warrants
ZEOWW
$12.5K ﹤0.01%
+250,000
New +$13.1K
TLGYW
82
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$12.5K ﹤0.01%
+250,000
New +$10.3K
BKSY.WS icon
83
BlackSky Technology Inc Warrants
BKSY.WS
$65.9K
$10.5K ﹤0.01%
+350,000
New +$12.4K
VSTEW
84
DELISTED
Vast Renewables Limited Warrants
VSTEW
$10K ﹤0.01%
+200,000
New +$14.6K
PGYWW
85
Pagaya Technologies Ltd Warrants
PGYWW
$1.34M
$8.76K ﹤0.01%
+48,661
New +$9.03K
RCFA.WS
86
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$8.75K ﹤0.01%
+175,000
New +$10.4K
GTACW
87
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$7.5K ﹤0.01%
+150,000
New +$8.78K
PHYT.WS
88
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$6K ﹤0.01%
+100,000
New +$5.34K
WALDW icon
89
Waldencast PLC Warrant
WALDW
$3.8M
$5.33K ﹤0.01%
+33,333
New +$5.01K
BTM
90
DELISTED
Bitcoin Depot
BTM
$4.94K ﹤0.01%
+446
New +$5.1K
QBTS.WS
91
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$4.5K ﹤0.01%
+50,000
New +$5.32K
HAIAW
92
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$4.5K ﹤0.01%
+150,000
New +$5.05K
FOXO
93
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$4.48K ﹤0.01%
+592
New +$2.3K
KPLTW
94
DELISTED
Katapult Holdings Warrant
KPLTW
$4K ﹤0.01%
+400,000
New +$3.88K
NVNIW
95
Nvni Group Limited Warrants
NVNIW
$836K
$4K ﹤0.01%
+200,000
New +$6.44K
FIACW
96
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$4K ﹤0.01%
+100,000
New +$3.76K
CXAIW icon
97
CXApp Inc Warrant
CXAIW
$955K
$3.13K ﹤0.01%
+12,500
New +$2.79K
BCSAW
98
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$3K ﹤0.01%
+150,000
New +$9.59K
BTMWW
99
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$2.5K ﹤0.01%
+50,000
New +$2.35K
ZCARW
100
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$2.5K ﹤0.01%
+250,000
New +$3.88K

Similar funds

Blue Owl Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Blue Owl Capital Holdings held 140 positions worth $518M, up 44% from $360M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Blue Owl Capital Holdings deployed $131M of net new capital in Q3 2024, opening 98 new positions and adding to 11 existing holdings. Its largest new stake was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 72% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ultragenyx Pharmaceutical, an estimated $5.35M trimmed.

  • Blue Owl Capital Holdings's largest Q3 2024 buy was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.
  • Blue Owl Capital Holdings added most to enGene Therapeutics in Q3 2024, an estimated $4.53M increase.
  • Blue Owl Capital Holdings's biggest Q3 2024 reduction was Ultragenyx Pharmaceutical, cutting an estimated $5.35M.
  • Blue Owl Capital Holdings fully exited Toast in Q3 2024, selling an estimated $8.31M.
  • Blue Owl Capital Holdings's ten largest holdings make up 65% of its $518M portfolio in Q3 2024.
  • Blue Owl Capital Holdings opened 98 new positions and closed 3 in Q3 2024.
  • Blue Owl Capital Holdings's portfolio value rose 44% quarter-over-quarter to $518M.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.